Comparative Study Between Different Approaches to CPA-petroclival Meningiomas
NCT03462914 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2018-03-13
Summary
• Give an effective treatment for CPA-petroclival meningiomas and can detect the best approach for these tumors.
. Improve the outcome of these patients and decease rate of recurrence.
Conditions
- Brain Neoplasms
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-03-15
- Primary Completion
- 2019-04-01
- Completion
- 2019-05-01
More Related Trials
-
Retrospective Study on Leptomeningeal Metastasis of Solid Tumors
NCT06705049 ·Status: ENROLLING_BY_INVITATION
-
Long-term Cognitive and Functional Impact of Proton-therapy or Modern Fractionated Radiotherapy in Cavernous Sinus Meningioma: An Open-label Randomized 1:1 Phase III Study
NCT05895344 ·Status: RECRUITING ·Phase: NA
-
A Twenty-years' Experience in Pituitary Disease.
NCT06973824 ·Status: RECRUITING
-
MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck Cancer
NCT00984074 ·Status: COMPLETED
-
A Prospective Study of the Impact of Hippocampal Avoidance During Whole Brain Radiotherapy on Neurocognitive Function Decline
NCT02504788 ·Status: RECRUITING ·Phase: NA
-
Neurococognitive and Functioal Assessment of Patients With Brain Metastases
NCT01861405 ·Status: UNKNOWN
-
The Predictive Factors of Vision Recovery in Patients With Pituitary Tumor
NCT01377701 ·Status: UNKNOWN
-
Neurocognitive Outcome Assesment in Patients With Peri-optic Meningiomas After Excision With Or Without Pealing Of The Outer Layer Of The Cavernous Sinus: A Randomized Controlled Single Blinded Trial.
NCT03190122 ·Status: UNKNOWN ·Phase: PHASE4
-
Hypofractionated Stereotactic Radiation Therapy of Brain Metastases: Evaluation of Whole-brain Radiotherapy
NCT02913534 ·Status: COMPLETED
-
The Efficacy of APT Magnetic Resonance Imaging in Predicting the Efficacy of Bevacizumab in Recurrent Malignant Gliomas
NCT03180697 ·Status: UNKNOWN
-
Response Prediction for Anti-angiogenic Treatment in Recurrent Glioblastoma
NCT04143425 ·Status: COMPLETED
-
Cavity Boost Radiation Therapy vs. Observation in Cerebral Metastases After Complete Surgical Resection
NCT02887651 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Factors in Human Brain Tumors
NCT00001171 ·Status: COMPLETED
-
Multicenter Retrospective Study on Patients Treated with Stereotactic Radiosurgery/Radiotherapy for Single Brain Lesions: Evaluation of Treatment Efficacy and Safety, Also Through Radiomic Analysis Methods.
NCT06869460 ·Status: ACTIVE_NOT_RECRUITING
-
PET (FDG)-MR Imaging for the Adult Patients Presented With Brain Tumor
NCT02071017 ·Status: UNKNOWN
-
Memory Preservation of Hippocampal Avoidance Whole Brain Radiotherapy
NCT03247127 ·Status: UNKNOWN ·Phase: NA
-
Impact of Image-defined Risk Factors on the Outcome of Patients With Neuroblastoma: A Retrospective Study
NCT02558244 ·Status: UNKNOWN
-
Pituitary Tumor Surveillance: Pathogenic Correlation
NCT00599092 ·Status: RECRUITING
-
Multisession Radiosurgery in Large Meningiomas
NCT02974127 ·Status: UNKNOWN
-
Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis
NCT06417710 ·Status: RECRUITING
-
Personalized Translational Platform for Biomarker Discovery in Brain Tumors
NCT01240161 ·Status: COMPLETED
-
Evaluation of Brain Functional Changes With 18F-FDG PET and Cognitive Processes After Brain Radiotherapy for Cavernous Sinus Meningiomas and Non-secreting ACTH Adenomas
NCT06180226 ·Status: COMPLETED
-
Integrated PET/MRI and Germline Variants to Differentiate Brain Tumopr Recurrence From Iatrogenicchanges in Children
NCT06226519 ·Status: RECRUITING
-
Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's Patients
NCT03903419 ·Status: UNKNOWN ·Phase: NA
-
Establishment and Clinical Application of Risk Classification Model Based on Molecular Typing of Medulloblastoma in Children
NCT05406947 ·Status: NOT_YET_RECRUITING